Search research articles
Contact Us
Filters
Showing results (101-110 of 154) with videos related to
Page
of 16
Sort By:
Journal of Alzheimer'S Disease : JAD
|
February 13, 2021
The Utility of Assessing Health-Related Quality of Life to Predict Cognitive Decline and Dementia
Aung Zaw Zaw Phyo, David A Gonzalez-Chica, Nigel P Stocks, et al.
Clinical Chemistry
|
January 12, 2012
Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study
David E Godler, Howard R Slater, Quang M Bui, et al.
JAMA Network Open
|
July 25, 2024
Low-Dose Aspirin and Progression of Age-Related Hearing Loss: A Secondary Analysis of the ASPREE Randomized Clinical Trial
David P Q Clark, Zhen Zhou, Sultana M Hussain, et al.
Journal of Alzheimer'S Disease Reports
|
October 7, 2020
Normative Data for the Symbol Digit Modalities Test in Older White Australians and Americans, African-Americans, and Hispanic/Latinos
Joanne Ryan, Robyn L Woods, Carlene J Britt, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 15, 2012
Carbon dioxide insufflation in open-chamber cardiac surgery: a double-blind, randomized clinical trial of neurocognitive effects
Krish Chaudhuri, Elsdon Storey, Geraldine A Lee, et al.
General Hospital Psychiatry
|
September 12, 2017
Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults
Mohammadreza Mohebbi, Van Nguyen, John J McNeil, et al.
The Medical Journal of Australia
|
July 22, 2008
Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study
Mark R Nelson, Christopher M Reid, David A Ames, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
September 17, 2016
ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly
Stephanie A Ward, Parnesh Raniga, Nicholas J Ferris, et al.
Neuro-Degenerative Diseases
|
September 8, 2016
Novel Blood Biomarkers Are Associated with White Matter Lesions in Fragile X- Associated Tremor/Ataxia Syndrome
Danuta Z Loesch, Sarah J Annesley, Nicholas Trost, et al.
International Journal of Geriatric Psychiatry
|
April 17, 2019
Prevalence of depressive symptoms and its associated factors among healthy community-dwelling older adults living in Australia and the United States
Mohammadreza Mohebbi, Bruno Agustini, Robyn L Woods, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 154) with videos related to
Sort By:
Page
of 16
Journal of Alzheimer'S Disease : JAD
|
February 13, 2021
The Utility of Assessing Health-Related Quality of Life to Predict Cognitive Decline and Dementia
Aung Zaw Zaw Phyo, David A Gonzalez-Chica, Nigel P Stocks, et al.
Clinical Chemistry
|
January 12, 2012
Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study
David E Godler, Howard R Slater, Quang M Bui, et al.
JAMA Network Open
|
July 25, 2024
Low-Dose Aspirin and Progression of Age-Related Hearing Loss: A Secondary Analysis of the ASPREE Randomized Clinical Trial
David P Q Clark, Zhen Zhou, Sultana M Hussain, et al.
Journal of Alzheimer'S Disease Reports
|
October 7, 2020
Normative Data for the Symbol Digit Modalities Test in Older White Australians and Americans, African-Americans, and Hispanic/Latinos
Joanne Ryan, Robyn L Woods, Carlene J Britt, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 15, 2012
Carbon dioxide insufflation in open-chamber cardiac surgery: a double-blind, randomized clinical trial of neurocognitive effects
Krish Chaudhuri, Elsdon Storey, Geraldine A Lee, et al.
General Hospital Psychiatry
|
September 12, 2017
Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults
Mohammadreza Mohebbi, Van Nguyen, John J McNeil, et al.
The Medical Journal of Australia
|
July 22, 2008
Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study
Mark R Nelson, Christopher M Reid, David A Ames, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
September 17, 2016
ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly
Stephanie A Ward, Parnesh Raniga, Nicholas J Ferris, et al.
Neuro-Degenerative Diseases
|
September 8, 2016
Novel Blood Biomarkers Are Associated with White Matter Lesions in Fragile X- Associated Tremor/Ataxia Syndrome
Danuta Z Loesch, Sarah J Annesley, Nicholas Trost, et al.
International Journal of Geriatric Psychiatry
|
April 17, 2019
Prevalence of depressive symptoms and its associated factors among healthy community-dwelling older adults living in Australia and the United States
Mohammadreza Mohebbi, Bruno Agustini, Robyn L Woods, et al.
Page
of 16